Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor

BACKGROUND: Cryptosporidium spp. is a protozoan parasite that infects many vertebrate animals, including humans. Since Cryptosporidium spp. can cause chronic life-threatening diarrhea and severe malabsorption in immunocompromised patients, we investigated the prevalence of this parasite among patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mehmet Karabey, Hüseyin Can, Tülay Öncü Öner, Mert Döşkaya, Sedef Erkunt Alak, Aysu Değirmenci Döşkaya, Muhammet Karakavuk, Ahmet Efe Köseoğlu, Cemal Ün, Adnan Yüksel Gürüz, Ahmet Alacacıoğlu, Bayram Pektaş, Aytül Gül, Selçuk Kaya, Ayşegül Aksoy Gökmen
Formato: article
Lenguaje:EN
Publicado: King Faisal Specialist Hospital and Research Centre 2021
Materias:
R
Acceso en línea:https://doaj.org/article/5ce0dc472305430a993b3e4e3bd7da7c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5ce0dc472305430a993b3e4e3bd7da7c
record_format dspace
spelling oai:doaj.org-article:5ce0dc472305430a993b3e4e3bd7da7c2021-12-01T12:57:42ZCryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor10.5144/0256-4947.2021.2930975-44660256-4947https://doaj.org/article/5ce0dc472305430a993b3e4e3bd7da7c2021-09-01T00:00:00Zhttp://www.annsaudimed.net/doi/10.5144/0256-4947.2021.293https://doaj.org/toc/0256-4947https://doaj.org/toc/0975-4466BACKGROUND: Cryptosporidium spp. is a protozoan parasite that infects many vertebrate animals, including humans. Since Cryptosporidium spp. can cause chronic life-threatening diarrhea and severe malabsorption in immunocompromised patients, we investigated the prevalence of this parasite among patients undergoing chemotherapy for malignant solid tumors. OBJECTIVE: Investigate the prevalence of Cryptosporidium spp. in stool samples. DESIGN: Cross-sectional. SETTING: Tertiary care. PATIENTS AND METHODS: Stool samples were collected from adult patients with malignant solid tumors receiving chemotherapy and diarrhea. Cryptosporidium spp. prevalence was determined using Ziehl–Neelsen staining, ELISA, and real-time PCR targeting of the COWP gene. MAIN OUTCOME MEASURE: The prevalence of Cryptosporidium spp. in patients undergoing chemotherapy for malignant solid tumors. SAMPLE SIZE: 94 RESULTS: The prevalence was 2.1% (2/94), 5.3% (5/94), and 5.3% (5/94) as detected by Ziehl–Neelsen staining, real-time PCR and ELISA, respectively. The prevalence reached 8.5% (8/94) using all results obtained from the three methods. Among eight positive stool samples, four were positive by at least two different methods (Ziehl–Neelsen staining-ELISA or ELISA-real-time PCR) whereas the remaining four were positive by either ELISA or real-time PCR. CONCLUSION: These findings show the risk of cryptosporidiosis in cancer patients and the necessity to use at least two diagnostic methods during the diagnosis of cryptosporidiosis to reach more accurate and trustworthy results. LIMITATIONS: Further studies with a larger sample size are recommended. CONFLICT OF INTEREST: None.Mehmet KarabeyHüseyin CanTülay Öncü ÖnerMert DöşkayaSedef Erkunt AlakAysu Değirmenci DöşkayaMuhammet KarakavukAhmet Efe KöseoğluCemal ÜnAdnan Yüksel GürüzAhmet AlacacıoğluBayram PektaşAytül GülSelçuk KayaAyşegül Aksoy GökmenKing Faisal Specialist Hospital and Research CentrearticleMedicineRENAnnals of Saudi Medicine, Vol 41, Iss 5, Pp 293-298 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Mehmet Karabey
Hüseyin Can
Tülay Öncü Öner
Mert Döşkaya
Sedef Erkunt Alak
Aysu Değirmenci Döşkaya
Muhammet Karakavuk
Ahmet Efe Köseoğlu
Cemal Ün
Adnan Yüksel Gürüz
Ahmet Alacacıoğlu
Bayram Pektaş
Aytül Gül
Selçuk Kaya
Ayşegül Aksoy Gökmen
Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
description BACKGROUND: Cryptosporidium spp. is a protozoan parasite that infects many vertebrate animals, including humans. Since Cryptosporidium spp. can cause chronic life-threatening diarrhea and severe malabsorption in immunocompromised patients, we investigated the prevalence of this parasite among patients undergoing chemotherapy for malignant solid tumors. OBJECTIVE: Investigate the prevalence of Cryptosporidium spp. in stool samples. DESIGN: Cross-sectional. SETTING: Tertiary care. PATIENTS AND METHODS: Stool samples were collected from adult patients with malignant solid tumors receiving chemotherapy and diarrhea. Cryptosporidium spp. prevalence was determined using Ziehl–Neelsen staining, ELISA, and real-time PCR targeting of the COWP gene. MAIN OUTCOME MEASURE: The prevalence of Cryptosporidium spp. in patients undergoing chemotherapy for malignant solid tumors. SAMPLE SIZE: 94 RESULTS: The prevalence was 2.1% (2/94), 5.3% (5/94), and 5.3% (5/94) as detected by Ziehl–Neelsen staining, real-time PCR and ELISA, respectively. The prevalence reached 8.5% (8/94) using all results obtained from the three methods. Among eight positive stool samples, four were positive by at least two different methods (Ziehl–Neelsen staining-ELISA or ELISA-real-time PCR) whereas the remaining four were positive by either ELISA or real-time PCR. CONCLUSION: These findings show the risk of cryptosporidiosis in cancer patients and the necessity to use at least two diagnostic methods during the diagnosis of cryptosporidiosis to reach more accurate and trustworthy results. LIMITATIONS: Further studies with a larger sample size are recommended. CONFLICT OF INTEREST: None.
format article
author Mehmet Karabey
Hüseyin Can
Tülay Öncü Öner
Mert Döşkaya
Sedef Erkunt Alak
Aysu Değirmenci Döşkaya
Muhammet Karakavuk
Ahmet Efe Köseoğlu
Cemal Ün
Adnan Yüksel Gürüz
Ahmet Alacacıoğlu
Bayram Pektaş
Aytül Gül
Selçuk Kaya
Ayşegül Aksoy Gökmen
author_facet Mehmet Karabey
Hüseyin Can
Tülay Öncü Öner
Mert Döşkaya
Sedef Erkunt Alak
Aysu Değirmenci Döşkaya
Muhammet Karakavuk
Ahmet Efe Köseoğlu
Cemal Ün
Adnan Yüksel Gürüz
Ahmet Alacacıoğlu
Bayram Pektaş
Aytül Gül
Selçuk Kaya
Ayşegül Aksoy Gökmen
author_sort Mehmet Karabey
title Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
title_short Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
title_full Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
title_fullStr Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
title_full_unstemmed Cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
title_sort cryptosporidium spp. during chemotherapy: a cross-sectional study of 94 patients with malignant solid tumor
publisher King Faisal Specialist Hospital and Research Centre
publishDate 2021
url https://doaj.org/article/5ce0dc472305430a993b3e4e3bd7da7c
work_keys_str_mv AT mehmetkarabey cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT huseyincan cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT tulayoncuoner cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT mertdoskaya cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT sedeferkuntalak cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT aysudegirmencidoskaya cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT muhammetkarakavuk cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT ahmetefekoseoglu cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT cemalun cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT adnanyukselguruz cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT ahmetalacacıoglu cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT bayrampektas cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT aytulgul cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT selcukkaya cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
AT aysegulaksoygokmen cryptosporidiumsppduringchemotherapyacrosssectionalstudyof94patientswithmalignantsolidtumor
_version_ 1718405174768173056